Psivida

                   

Biotech down under

globes.co.il     Jul 23, 2008          

Brian Leedman, VP investor relations at Australian biotech company Psivida, tells "Globes" what the Australian and Israeli industries have in common. "The biotech community in Western Australia is slightly smaller than that in...                

comments

                   
genengnews.com: Genetic Engineering genengnews.com

pSivida Announces New Board Appointments

redorbit.com     Jul 14, 2008   2 related          

pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a leading drug delivery company headquartered in Watertown, MA, today announced the appointment to their Board of Directors of Peter G. Savas and Paul A. Hopper as non-executive...                

comments

                   

pSivida Corp: BrachySil™ Phase IIb Pancreatic Cancer Trials Commence

medicalnewstoday.com     Jul 9, 2008   2 related          

pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a global drug delivery company announced that a Phase IIb clinical trial has commenced with BrachySil™ (P32 BioSilicon™) as a potential new brachytherapy treatment for inoperable...                

comments

                   

Alimera Files IPO as Experts Predict Capital Markets Crisis

tmcnet.com     Jul 2, 2008          

The Alpharetta, Ga.-based company plans to list on Nasdaq under the ticker "ALIM." Alimera's proposal follows filings from Aldagen Inc., BioTrove Inc., Zogenix Inc., CyDex Pharmaceuticals Inc., Phenomix Corp., Bayhill...                

comments

                   

pSivida Announces Interim Results From The Three-Month Readout Of The Human PK MedidurTM FA Study

medicalnewstoday.com     Jul 1, 2008          

Global drug delivery company, pSivida Corp. (NASDAQ: PSDV)(ASX: PVA)(FSE: PSI) today reported the interim three-month safety and efficacy results from the first human pharmacokinetic(1) (PK) study of Medidur™ FA, in patients...                

comments

pSivida Corp. (PSDV) Managing Director to Ring the NASDAQ Stock Market Closing Bell

primenewswire.com     Jun 30, 2008   3 related          

ADVISORY, June 30, 2008 (PRIME NEWSWIRE) -- What: Paul Ashton, Managing Director of pSivida Corp. (PSDV), will preside over the Closing Bell. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When:...                

comments

                   

pSivida Announces Interim Results from the Three-Month Readout of the Human PK Medidur FA Study

drugs.com     Jun 27, 2008   10 related          

BOSTON & PERTH, Australia--(BUSINESS WIRE)--Jun 26, 2008 - Global drug delivery company, pSivida Corp. (NASDAQ: PSDV)(ASX: PVA)(FSE: PSI) today reported the interim three-month safety and efficacy results from the first human...                

comments

                   

InPlay: DuPont: wew DuPont molecular markers increase soybean productivity (Briefing.com)

yahoo.com     Jun 26, 2008   22 related          

10:50AM pSivida announces interim results from the three-month readout of the human PK Medidur FA study 2.60 +1.65 : Co reports the interim three-month safety and efficacy results from the first human pharmacokinetic study of...                

comments

                   

pSivida Announces Symbol Change back to PSDV

euroinvestor.co.uk     Jun 26, 2008          

pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FSE:PSI) today announced that the symbol for its common stock, traded on NASDAQ has returned to PSDV today. Vitrasert® is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch...                

comments

                   

pSivida Discusses Reincorporation in Open Briefing Interview

finanznachrichten.de     Jun 23, 2008   2 related          

pSivida Corp. (NASDAQ:PSDVV)(ASX:PVA)(FWB:PSI) today announced that a discussion of the implementation of the Scheme of Arrangement for pSivida's reincorporation in the US has been filed in an Open Briefing interview....                

comments

1 2 3 4 next »